Immunology

Targeting the treatment of autoimmune diseases

A team of researchers from Charité–Universitätsmedizin Berlin and the Deutsches Rheuma-Forschungszentrum (DRFZ) Berlin, a Leibniz Institute, have successfully treated two patients with the autoimmune disease systemic ...

Medical research

A protein for the mass production of antibodies

Antibodies play a fundamental role in medicine, and antibody-mediated immune response is the ultimate target in the quest for a vaccine to defeat the current pandemic. These minute proteins, also called immunoglobulins, are ...

Diseases, Conditions, Syndromes

Small study supports donor plasma therapy for severe COVID-19

(HealthDay)—Using the donated blood plasma of COVID-19 survivors to treat patients in the throes of severe coronavirus illness has met with some controversy. But a small new study suggests it could have real merit.

Diseases, Conditions, Syndromes

Convalescent plasma is latest COVID-19 therapy

Richard Beckerson will never know whether it was convalescent plasma that made the lifesaving difference—or whether it was the antiviral drug remdesivir or a combination of both.

Medical research

Metabolite signature of COVID-19 reveals multi-organ effects

SARS-CoV-2, the virus responsible for COVID-19, can cause a wide range of symptoms, from none at all to severe respiratory stress, multi-organ failure and death. The virus notably targets the lungs, but many patients also ...

Diseases, Conditions, Syndromes

Egypt tries plasma treatment to fight pandemic

Mohamed Fathi, an Egyptian man who has recovered from COVID-19, winced as he watched tubes running down his arm to donate blood plasma, but insisted: "if I can help just one person, that's a very good thing".

page 29 from 40